PharmaCyte Biotech Inc (PMCB)
2.13
-0.03
(-1.39%)
USD |
NASDAQ |
Apr 24, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| October 31, 2012 | -53.01% |
| July 31, 2012 | |
| April 30, 2012 | |
| January 31, 2012 | 89.09% |
| October 31, 2011 | 69.58% |
| July 31, 2011 | 20.68% |
| April 30, 2011 | 99.33% |
| January 31, 2011 | 31.36% |
| October 31, 2010 | 82.02% |
| July 31, 2010 | 74.31% |
| April 30, 2010 | -80.20% |
| January 31, 2010 | 39.58% |
| October 31, 2009 | 25.94% |
| July 31, 2009 | 38.49% |
| April 30, 2009 | -256.9% |
| January 31, 2009 | 76.01% |
| October 31, 2008 | 58.29% |
| Date | Value |
|---|---|
| July 31, 2008 | 81.25% |
| April 30, 2008 | 77.99% |
| January 31, 2008 | 80.91% |
| October 31, 2007 | 80.86% |
| July 31, 2007 | 70.93% |
| April 30, 2007 | |
| January 31, 2007 | |
| October 31, 2006 | |
| July 31, 2006 | |
| April 30, 2006 | |
| January 31, 2006 | |
| October 31, 2005 | |
| July 31, 2005 | |
| April 30, 2005 | |
| January 31, 2005 | |
| October 31, 2004 | |
| July 31, 2004 | 66.91% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |